Page
|
||||
About
This Prospectus
|
2
|
|||
Special
Note Regarding Forward-Looking Statements
|
2
|
|||
Prospectus
Summary
|
3
|
|||
Risk
Factors
|
4
|
|||
Use
of Proceeds
|
6
|
|||
Selling
Shareholders
|
6
|
|||
Plan
of Distribution
|
10
|
|||
Legal
Matters
|
11
|
|||
Experts
|
11
|
|||
Where
You Can Find More Information
|
11
|
· |
lower
labor and administrative costs associated with fueling
vehicles
|
· |
centralized
control over fuel inventories and
usage
|
· |
tax,
utilization and other reporting
benefits
|
· |
elimination
of costs and the risk of environmental liabilities associated with
on-site
fuel storage and dispensing
facilities
|
· |
lower
risk of employee theft of fuel
|
· |
emergency
fuel availability and
|
· |
the
elimination of security risks associated with off-site fueling
by
employees.
|
Securities
Offered by the Selling Shareholders
|
1,495,000
shares of common stock.
|
Use
of Proceeds
|
We
will receive up to $1,610,400 upon the exercise of the warrants
by the
selling shareholders. We will not receive any of the proceeds from
the
sale of the common stock or warrants by the selling
shareholders.
|
Trading
|
Our
common stock is quoted on the Nasdaq SmallCap Market under the
symbol
“FUEL.”
|
· |
1,006,500
are issuable to certain selling shareholders upon the exercise
of warrants
issued in a private placement in January 2005;
and
|
· |
488,500
are issuable upon the conversion of the principal and interest
of a two
year contingent deferred promissory note into our common stock
in a
private placement in February 2005 (which is not currently
convertible).
|
· |
Leonid
Frenkel is the manager of a limited liability company which acts
as the
general partner of both Triage Capital Management L.P. and Triage
Capital
Management B, L.P. Mr. Frenkel acts as the manager of a limited
liability
company that acts as general partner to an investment manager of
Triage
Offshore Fund, Ltd. Mr. Frankel also acts as the general partner
to
Periscope Partners L.P. He disclaims beneficial ownership of the
Company’s
securities held by those entities except to the extent of his pecuniary
interest therein.
|
Name
and Address of Beneficial Owner
|
Ownership
of Shares
Before
the Offering
|
Ownership
After
the
Offering
|
||||||||
Currently
Held
Shares
|
Shares
Issuable
Upon
Conversion
of
Warrants
and
Note
|
Percentage
|
Number
of
Shares
Registered
|
Shares
|
Percentage
|
|||||
LES
R. BALEDGE
668
N. Sequoyah Drive
Fayetteville,
AR 72701
|
142,000(1)
|
142,000
|
1.58%
|
142,000
|
0
|
0
|
||||
COHANZICK
CREDIT OPPORTUNITIES MASTER FUND, LTD
c/o
David K. Sherman, Authorized Agent
427
Bedford Road, Suite 260
Pleasantville,
NY 10570
|
142,000(1)
|
142,000
|
1.58%
|
142,000
|
0
|
0
|
||||
TRIAGE
OFFSHORE FUND, LTD.
c/o
Triage Advisors
401
City Avenue, Suite 526
Bala
Cynwyd, PA 19004
|
218,340(2)
|
131,208
|
2.42%
|
131,208
|
87,132
|
*
|
||||
TRIAGE
CAPITAL MANAGEMENT, L.P.
c/o
Leon Frenkel, Sr. Manager
401
City Avenue, Suite 526
Bala
Cynwyd, PA 19004
|
28,625(2)
|
17,040
|
*
|
17,040
|
11,585
|
*
|
||||
TRIAGE
CAPITAL MANAGEMENT B, L.P.
c/o
Leon Frenkel, Sr. Manager
401
City Avenue, Suite 526
Bala
Cynwyd, PA 19004
|
45,469(2)
|
22,152
|
*
|
22,152
|
23,317
|
*
|
||||
CAPITAL
PROPERTIES LLC
c/o
Gus Blass III, General Manager
212
Center Street, Suite 800
Little
Rock, AR 72201
|
133,500(3)
|
71,000
|
1.50%
|
71,000
|
62,500
|
*
|
Name
and Address of Beneficial Owner
|
Ownership
of Shares
Before
the Offering
|
Ownership
After
the
Offering
|
||||||||
Currently
Held
Shares
|
Shares
Issuable
Upon
Conversion
of
Warrants
and
Note
|
Percentage
|
Number
of
Shares
Registered
|
Shares
|
Percentage
|
GUS
BLASS, II
10
W. Palisades Dr.
Little
Rock, AR 72207
|
71,000(4)
|
71,000
|
*
|
71,000
|
0
|
0
|
||||
CONSTANCE
BLASS O’NEILL TRUST #3
Patricia
B. Blass, Trustee
16
W. Palisades Dr.
Little
Rock, AR 72207
|
42,600(5)
|
42,600
|
*
|
42,600
|
0
|
0
|
||||
GABRIEL
CAPITAL, L.P.
c/o
David K. Sherman, Authorized Agent
450
Park Avenue, Suite 3201
New
York, NY 10022
|
147,000(6)
|
142,000
|
1.64%
|
142,000
|
5,000
|
*
|
||||
PERISCOPE
PARTNERS L.P.
c/o
Leon Frenkel, General Partner
1600
Flat Rock Rd.
Penn
Valley, PA 19072
|
42,600(7)
|
42,600
|
*
|
42,600
|
0
|
0
|
||||
MARK
D. WITTMAN
20
Beacon Hill Lane
Phoenixville,
PA 19460
|
19,600(8)
|
7,100
|
*
|
7,100
|
12,500
|
*
|
||||
AMBER
FUND, LTD.
c/o
David K. Sherman, Authorized Agent
450
Park Avenue, Suite 3201
New
York, NY 10022
|
35,500(9)
|
35,500
|
*
|
35,500
|
0
|
0
|
||||
JAMES
ALSOPP
1717
Spruce Street #3F
Philadelphia,
PA 19103
|
19,234(10)
|
10,000
|
*
|
10,000
|
9,234
|
*
|
||||
ROBERT
FISK
104
Dilworthtown Road
Thornton,
PA 19373
|
54,050(11)
|
54,050
|
*
|
54,050
|
0
|
0
|
||||
KEVIN
HAMILTON
P.O.
Box 111
Wycombe,
PA 18980
|
13,950(12)
|
13,950
|
*
|
13,950
|
0
|
0
|
||||
ROBERT
JACOBS
175
Berwind Circle
Radnor,
PA 19087
|
55,723(13)
|
18,600
|
*
|
18,600
|
37,123
|
*
|
||||
SEAN
MCDERMOTT
236
B Queen Street
Philadelphia,
PA 19147
|
13,950(14)
|
13,950
|
*
|
13,950
|
0
|
0
|
||||
BERNADETTE
PUCILLO
1501
Darby Road
Havertown,
PA 19083
|
5,000(15)
|
5,000
|
*
|
5,000
|
0
|
0
|
||||
MARK
ZIMMER
40
Junction Road
South
Berwick, ME 03908
|
34,750(16)
|
24,750
|
*
|
24,750
|
10,000
|
*
|
||||
JERRY
C. AND CLAUDETTE SHANKLIN
9611
Windrush
Spring,
TX 77379
|
488,500(17)
|
488,500
|
5.24%
|
488,500
|
0
|
0
|
||||
Total
|
1,753,391
|
1,495,000
|
1,495,000
|
258,391
|
(1) |
Consists
of 142,000 issuable upon the exercise of warrants that are presently
exercisable.
|
(2) |
The
holdings of Triage Management LLC consist of warrants that are
owned and
presently exercisable by Triage Offshore Fund, Ltd. (194,946 warrants),
Triage Capital Management, L.P.(25,575 warrants), and Triage Capital
Management B, L.P. (41,513
warrants).
|
(3) |
Includes
71,000 shares issuable upon the exercise of warrants that are presently
exercisable.
|
(4) |
Consists
of 71,000 issuable upon the exercise of warrants that are presently
exercisable.
|
(5) |
Consists
of 42,600 shares issuable upon the exercise of warrants that are
presently
exercisable.
|
(6) |
Includes
142,000 shares issuable upon the exercise of warrants that are
presently
exercisable.
|
(7) |
Consists
of 42,600 shares issuable upon the exercise of warrants that are
presently
exercisable.
|
(8) |
Includes
19,600 shares issuable upon the exercise of warrants that are presently
exercisable.
|
(9) |
Consists
of 35,500 shares issuable upon the exercise of warrants that are
presently
exercisable.
|
(10) |
Includes
19,234 shares issuable upon the exercise of warrants that are presently
exercisable.
|
(11) |
Consists
of 54,050 shares issuable upon the exercise of warrants that are
presently
exercisable.
|
(12) |
Consists
of 13,950 shares issuable upon the exercise of warrants that are
presently
exercisable.
|
(13) |
Includes
55,723 shares issuable upon the exercise of warrants that are presently
exercisable.
|
(14) |
Consists
of 13,950 shares issuable upon the exercise of warrants that are
presently
exercisable.
|
(15) |
Consists
of 5,000 shares issuable upon the exercise of warrants that are
presently
exercisable.
|
(16) |
Includes
24,750 shares issuable upon the exercise of warrants that are presently
exercisable.
|
(17) |
Consists
of 488,500 shares issuable upon the conversion of a two year contingent
deferred promissory note which is not presently convertible. The
number of
shares into which the note is convertible is limited so that the
number of
shares that are paid, when taken together with the number of shares
issuable upon conversion of the warrants issued in connection with
our
offering of 10% Senior Secured Notes due 2010, must be less than
20% of
the number of shares of Common Stock outstanding on February 18,
2005 (20%
of 7,475,101 shares, or 1,494,000 shares) in accordance with Nasdaq
Stock
Market Rule 4350(i)(I)(C) or any successor rule.
|
· |
on
the Nasdaq SmallCap Market,
|
· |
in
the over-the-counter market,
|
· |
in
privately negotiated transactions,
|
· |
for
settlement of short sales, or through long sales, options or transactions
involving cross or block trades,
|
· |
by
pledges to secure debts and other obligations,
or
|
· |
in
a combination of any of these
transactions.
|
· |
fixed
prices which may be changed,
|
· |
market
prices prevailing at the time of
sale,
|
· |
prices
related to prevailing market prices,
or
|
· |
privately
negotiated prices.
|
· |
directly
to purchasers, or
|
· |
to
or through agents, brokers, dealers or underwriters designated
from time
to time.
|
· |
Our
Annual Report on Form 10-K for the fiscal year ended June 30, 2004;
|
· |
Our
Quarterly Reports on Form 10-Q for the quarterly periods ended
September
30, 2004, December 31, 2004 and March 31,
2005;
|
· |
All
other reports filed pursuant to Section 13(a) or 15(d) of the Exchange
Act
filed since June 30, 2004;
|
· |
Our
definitive Proxy Statement filed on October 28, 2004;
and
|
· |
The
description of our common stock contained in the Registration Statement
on
Form 8-A filed on December 5, 1996, and as amended December 10,
1996,
under Section 12(g) of the Exchange
Act.
|